From Manual to Seamless: Transforming SAE Reconciliation with Integrated Platforms

Serious adverse event (SAE) reconciliation is a critical component of clinical trial conduct, ensuring alignment between clinical data capture systems and pharmacovigilance databases to protect patient safety and maintain regulatory compliance. Traditionally, reconciliation is a manual, resource-intensive process that can delay database lock, complicate discrepancy management, and hinder timely safety signal detection.

Integrated data platforms offer an opportunity to transform SAE reconciliation by enabling near real-time data exchange between electronic data capture (EDC) and safety systems. Through standardized data structures, automated checks, and centralized workflows, these platforms reduce duplication, minimize discrepancies, and streamline operational processes. In addition, they support earlier detection of safety issues, strengthen collaboration across data management, pharmacovigilance, and clinical operations, and provide a transparent audit trail for regulatory inspections.

By shifting reconciliation from a retrospective exercise to a proactive, technology-enabled process, integrated platforms have the potential to improve efficiency, data quality, and patient safety oversight across clinical trials.